Related Experiment Video
Updated: May 24, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diabetes screening among immigrants: a population-based urban cohort study
Maria I Creatore1, Gillian L Booth, Douglas G Manuel
1Centre for Research on Inner City Health, St. Michael's Hospital, Toronto, Ontario, Canada. creatorem@smh.ca
Diabetes Care
|February 24, 2012
Summary
Diabetes screening rates are high in Canada, even for immigrants. However, disparities persist among immigrant subgroups, with multiple doctor visits often needed for recommended screening.
Area of Science:
- Public Health
- Epidemiology
- Health Services Research
Background:
- Diabetes screening is crucial for early detection and management.
- Understanding screening patterns in diverse populations, including immigrants, is essential for health equity.
Purpose of the Study:
- To analyze diabetes screening rates, identify predictors of screening, and estimate the burden of undiagnosed diabetes among immigrants in Ontario, Canada.
- To investigate ethnic variations in diabetes screening and diagnosis within the immigrant population.
Main Methods:
- A population-based retrospective cohort study linked administrative health data with immigration files.
- Followed 3,484,222 diabetes-free individuals aged 40+ in Ontario from 2004-2007 to assess diabetes screening.
- Multivariate regression analysis identified predictors of diabetes testing.
Main Results:
- Immigrant populations had slightly higher overall diabetes screening rates (76.0%) than the general population (74.4%).
- Screening rates varied significantly by country of birth, with highest yields of new diabetes cases in South Asia, Mexico, Latin America, and the Caribbean.
- Immigrant seniors (≥65 years) were screened less than nonimmigrant seniors, and multiple physician visits were often required for high-risk ethnic groups.
Conclusions:
- Canada's universal healthcare system supports high diabetes screening rates, including for high-risk immigrant groups.
- Disparities in screening rates exist among different immigrant subgroups.
- Efforts are needed to ensure equitable access to recommended diabetes screening levels for all immigrant populations.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...